Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jason Hsu (NPI 1548218787)

Field	Value
Entity Type	Individual
Organization	Jason Hsu
Address	4060 Butler Pike
City	Plymouth Meeting
State	PA
ZIP	19462
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 4, 2006

Payer Source	Total Paid
Medicare	$4.4M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue: $4.4M and there is no Medicaid billing on file, so Medicare accounts for the entirety of the reported public‑payer activity. That concentration means analyses of payer mix and reimbursement risk should focus on Medicare claims patterns and reimbursement dynamics alone for this NPI.

Revenue is highly concentrated in a small set of intravitreal drug and procedure codes: the precomputed top 3 Medicare codes by revenue account for 77.5% of this provider's total Medicare revenue. Specifically, J0178 generates $2.2M (50.5% of total Medicare revenue), J2777 generates $960.5K (21.8%), and 67028 generates $232.4K (5.3%), pointing to a business model driven by a few high‑value services.

The code mix indicates a procedural, retina‑focused ophthalmology practice centered on intravitreal injections and retinal diagnostics: J0178 (aflibercept) and J2777 (faricimab) together dominate revenue and are supported by high volumes of retinal imaging (92134: 4.2K claims, $130.6K revenue) and intravitreal injection procedure coding (67028: 2.3K claims, $232.4K revenue). These patterns are consistent with an operation that delivers frequent anti‑VEGF therapy and associated diagnostic follow‑up.

Competitive standing for the top ophthalmic injection codes is well above typical national activity: J0178 ranks #142 of 3204 providers nationally (96th percentile; notably above typical national volume), J2777 ranks #250 of 2039 (88th percentile), and 67028 ranks #252 of 4255 (94th percentile). Together these ranks indicate the provider is a major national‑level contributor for intravitreal injections relative to peers.

Several procedure and visit codes are statistical outliers in national comparisons, underscoring concentrated service lines: 92012 (2.2K claims, $151.2K revenue) and 92134 (4.2K claims, $130.6K revenue) both register as 100th percentile extreme outliers, and 99204 (297 claims, $36.8K revenue) is a 99th percentile extreme outlier. These extreme‑outlier designations suggest abnormally high volumes of intermediate/established ophthalmic evaluations, retinal imaging, and higher‑complexity new patient visits compared with national peers.

The E/M and visit mix shows both high new‑patient and established‑patient activity: the high ranking of 99204 (99th percentile) alongside very large volumes of 92012 (100th percentile) and presence of 92014 and 99214 at more typical levels suggests the practice manages a steady flow of new consults and ongoing established care tied to procedural follow‑up. This pattern is consistent with a referral‑driven retinal practice where new patient evaluations lead to ongoing injection regimens.

There is a notable spread in drug unit economics and nonstandard drug use: J0178 averages $692 paid/claim while J2777 averages $29 paid/claim, and J3490 (unclassified drugs) shows $1,865 avg paid/claim with $100.7K revenue (2.3% of total). These differences reflect a mix of high‑cost drug administrations and lower per‑unit priced agents or billing of miscellaneous drug products, which has implications for inventory and reimbursement management.

The provider has long tenure on file (NPI enumerated 2006‑05‑04, ~20 years ago), which combined with the concentrated anti‑VEGF and retinal imaging volumes suggests an established specialty practice with a stable, Medicare‑centered revenue base and operational experience in intravitreal therapy delivery.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,220	$690	$2.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	33,120	$30	$960.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,300	$100	$232.4K
J2778	Injection, ranibizumab, 0.1 mg	1,150	$190	$218.1K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	810	$220	$176K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	2,220	$70	$151.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,210	$30	$130.6K
J3490	Unclassified drugs	50	$1,870	$100.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	760	$90	$69.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	530	$120	$63K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Jason Hsu — 3 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	15	140	830	$690	$865.1K
Q5128	21	20	3,830	$220	$838.7K
J2778	32	70	1,030	$190	$417.1K
J2777	9	100	7,950	$30	$360.2K
J2781	14	20	690	$120	$109.1K
67028	22	180	600	$90	$87.5K
J7999	54	110	100	$120	$33.3K
67042	31	50	20	$1,100	$31.9K
J3490	56	110	60	$70	$27.9K
92014	122	1,570	130	$80	$21K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jason Hsu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alok Bansal	CA	Ophthalmology Physician	$3M	$4.7M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Omesh Gupta	PA	Ophthalmology Physician	$7.1M	$80
Mitchell Fineman	PA	Ophthalmology Physician	$7M	$0
Michael Klufas	PA	Ophthalmology Physician	$7M	$0
Richard Kaiser	PA	Ophthalmology Physician	$6.6M	$0
Allen Chiang	PA	Ophthalmology Physician	$6.6M	$0
Carl Regillo	PA	Ophthalmology Physician	$6.5M	$0
Allen Ho	PA	Ophthalmology Physician	$6.4M	$0
Yoshihiro Yonekawa	PA	Ophthalmology Physician	$6.4M	$0

Nearby Providers

Other providers in the same ZIP code as Jason Hsu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Gemma Services	PA	Psychiatric Residential Treatment Facility	$0	$23.8M
Access Services Inc	PA	Community/Behavioral Health Agency	$0	$8.3M
James Vander	PA	Ophthalmology Physician	$6.3M	$0
Marc Spirn	PA	Ophthalmology Physician	$6.3M	$0
Arunan Sivalingam	PA	Ophthalmology Physician	$6M	$0
Sunir Garg	PA	Ophthalmology Physician	$6M	$0
Carl Park	PA	Ophthalmology Physician	$5.5M	$0
Ajay Kuriyan	PA	Ophthalmology Physician	$5.3M	$6.6K
Plymouth Community Ambulance Assn	PA	Land Ambulance	$903.5K	$4.3M
Sonia Mehta	PA	Ophthalmology Physician	$4.9M	$0

Jason Hsu — Billing Profile & Reimbursement Data

Sign up for Jason Hsu — Billing Profile & Reimbursement Data policy alerts

Jason Hsu — Billing Profile & Reimbursement Data

Sign up for Jason Hsu — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References